HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: R600004-MCP200v1 5/10/1760    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pisitkun, T. Articles by Knepper, M. A. Search for Related Content PubMed PubMed Citation Articles by Pisitkun, T. Articles by Knepper, M. A. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 5:1760-1771, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Cancer

Discovery of Urinary Biomarkers^*

Trairak Pisitkun, Rose Johnstone and Mark A. Knepper^,¶

From the Laboratory of Kidney and Electrolyte Metabolism, NHLBI, National Institutes of Health, Bethesda, Maryland 20892 and Department of Biochemistry, McGill University, Montreal, Quebec H3G 1Y6, Canada

A myriad of proteins and peptides can be identified in normal human urine. These are derived from a variety of sources including glomerular filtration of blood plasma, cell sloughing, apoptosis, proteolytic cleavage of cell surface glycosylphosphatidylinositol-linked proteins, and secretion of exosomes by epithelial cells. Mass spectrometry-based approaches to urinary protein and peptide profiling can, in principle, reveal changes in excretion rates of specific proteins/peptides that can have predictive value in the clinical arena, e.g. in the early diagnosis of disease, in classification of disease with regard to likely therapeutic responses, in assessment of prognosis, and in monitoring response to therapy. These approaches have potential value, not only in diseases of the kidney and urinary tract but also in systemic diseases that are associated with circulating small protein and peptide markers that can pass the glomerular filter. Most large scale biomarker discovery studies reported thus far have used one of two approaches to identify proteins and peptides whose excretion in urine changes in specific disease states: 1) two-dimensional electrophoresis with mass spectrometric and/or immunochemical identification of proteins and 2) top-down mass spectrometric methods (SELDI-TOF-MS and capillary electrophoresis-MS). These studies have been chiefly in the areas of nephrology, urology, and oncology. We review these applications, focusing on two areas of progress, viz. in bladder cancer and in acute rejection of renal transplants. Progress has been limited so far. However, with the advent of powerful LC-MS/MS methods along with methods for quantifying LC-MS/MS output, there is hope for an accelerated discovery and validation of disease biomarkers in urine.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Sonoda, N. Yokota-Ikeda, S. Oshikawa, Y. Kanno, K. Yoshinaga, K. Uchida, Y. Ueda, K. Kimiya, S. Uezono, A. Ueda, et al. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury Am J Physiol Renal Physiol, October 1, 2009; 297(4): F1006 - F1016. [Abstract] [Full Text] [PDF]

				D. M. Schlatzer, J.-E. Dazard, M. Dharsee, R. M. Ewing, S. Ilchenko, I. Stewart, G. Christ, and M. R. Chance Urinary Protein Profiles in a Rat Model for Diabetic Complications Mol. Cell. Proteomics, September 1, 2009; 8(9): 2145 - 2158. [Abstract] [Full Text] [PDF]

				K. Bramham, H.D. Mistry, L. Poston, L.C. Chappell, and A.J. Thompson The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant? QJM, August 1, 2009; 102(8): 523 - 538. [Abstract] [Full Text] [PDF]

				M. A. Knepper Common Sense Approaches to Urinary Biomarker Study Design J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1175 - 1178. [Full Text] [PDF]

				P. Saetun, T. Semangoen, and V. Thongboonkerd Characterizations of urinary sediments precipitated after freezing and their effects on urinary protein and chemical analyses Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1346 - F1354. [Abstract] [Full Text] [PDF]

				P. A. Gonzales, T. Pisitkun, J. D. Hoffert, D. Tchapyjnikov, R. A. Star, R. Kleta, N. S. Wang, and M. A. Knepper Large-Scale Proteomics and Phosphoproteomics of Urinary Exosomes J. Am. Soc. Nephrol., February 1, 2009; 20(2): 363 - 379. [Abstract] [Full Text] [PDF]

				C. Hudson, J. Hudson, M. Swaminathan, A. Shaw, M. Stafford-Smith, and U. D. Patel Emerging Concepts in Acute Kidney Injury Following Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2008; 12(4): 320 - 330. [Abstract] [PDF]

				C. M. Hegedus, C. F. Skibola, M. Warner, D. R. Skibola, D. Alexander, S. Lim, N. L. Dangleben, L. Zhang, M. Clark, R. M. Pfeiffer, et al. Decreased Urinary Beta-Defensin-1 Expression as a Biomarker of Response to Arsenic Toxicol. Sci., November 1, 2008; 106(1): 74 - 82. [Abstract] [Full Text] [PDF]

				P. Gonzales, T. Pisitkun, and M. A. Knepper Urinary exosomes: is there a future? Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1799 - 1801. [Full Text] [PDF]

				J. Yu, T. Zhu, Z. Wang, H. Zhang, Z. Qian, H. Xu, B. Gao, W. Wang, L. Gu, J. Meng, et al. A Novel Set of DNA Methylation Markers in Urine Sediments for Sensitive/Specific Detection of Bladder Cancer Clin. Cancer Res., December 15, 2007; 13(24): 7296 - 7304. [Abstract] [Full Text] [PDF]

				T. Pisitkun, J. D. Hoffert, M.-J. Yu, and M. A. Knepper Tandem Mass Spectrometry in Physiology Physiology, December 1, 2007; 22(6): 390 - 400. [Abstract] [Full Text] [PDF]

				J. Barratt MB ChB (Ho and P. Topham MB ChB MD Urine proteomics: the present and future of measuring urinary protein components in disease Can. Med. Assoc. J., August 14, 2007; 177(4): 361 - 368. [Abstract] [Full Text] [PDF]

				A. Cheruvanky, H. Zhou, T. Pisitkun, J. B. Kopp, M. A. Knepper, P. S. T. Yuen, and R. A. Star Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1657 - F1661. [Abstract] [Full Text] [PDF]

				A. G.W. Norden, P. Rodriguez-Cutillas, and R. J. Unwin Clinical Urinary Peptidomics: Learning to Walk Before We Can Run Clin. Chem., March 1, 2007; 53(3): 375 - 376. [Full Text] [PDF]